My Profile
Matthew Goldstein
Raising intellectual capital on Wall Street
See all posts
Thu 26 Nov 2009 | 1:20 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For deCODE genetics, Inc.
deCODE genetics, Inc. (DCGN.O) (Consolidated Issue listed on NASDAQ Global Market)
sector:
Healthcare
.
industry:
Biotechnology
ยท
View
DCGN
on other exchanges
As of 25 Nov 2009
0.03
USD
Price Change
-0.00
Percent Change
-8.57%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Age
Since
Current Position
Hartman, Daniel
47
2005
Senior Vice President - Product Development
Gurney, Mark
54
2005
Senior Vice President - Drug Discovery and Development
Sigurdsson, Jakob
45
2006
Senior Vice President - Corporate Development
Beery, James
68
2004
Director
Armstrong, J. Neal
71
2003
Director
Goodfellow, Peter
57
2006
Director
Nielsen, Axel
44
2007
Chief Operating Officer
Thibault, Lance
42
2001
Chief Financial Officer, Treasurer
Stefansson, Kari
60
1999
Chairman of the Board, President, Chief Executive Officer
Find out more about DCGN.O
Insider Trading